Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
Smiles: CCC1=C(C2C(=CC=CC=2N1CC1C=CC=CC=1)OCC(O)=O)C(=O)C(N)=O
Smiles: CC1C=NC(=CC=1)C1C=CC(C)=CN=1
Use of a quantitative proteomics approach confirmed the selectivity of CTx - 0294885 -bound beads for kinase enrichment
Hasinoff BB
WAY-100635 - CAS# 162760-96-5 eropenem A Phase II trial ofWAY 100635 is a piperazine drug and research chemical widely used in scientific studies. It was originally believed to act as a selective 5 HT1A receptor antagonist, but subsequent research showed that it also acts as potent full agonist at the D4 receptor. It is sometimes referred to as a silent antagonist at the former receptor. It is closely related to WAY 100,135. Product information CAS Number: 162760 96 5 Molecular Weight: 422. 56 Formula:
US$ 125.00
US$ 12.85
US$ 102.00